Combination therapy for rheumatoid arthritis: new paradigms of treatment.
Wilke
W S
WS
Department of Rheumatic and Immunologic Disease, Cleveland Clinic Foundation, OH 44195.
D018501:Antirheumatic Agents / Q000008:administration & dosage; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001310:Auranofin / Q000008:administration & dosage; D001379:Azathioprine / Q000008:administration & dosage; D002985:Clinical Protocols; D004359:Drug Therapy, Combination; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D010396:Penicillamine / Q000008:administration & dosage; D012189:Retrospective Studies; D012460:Sulfasalazine / Q000008:administration & dosage
D018501:Antirheumatic Agents; D001310:Auranofin; D012460:Sulfasalazine; D006886:Hydroxychloroquine; D010396:Penicillamine; D001379:Azathioprine; D008727:Methotrexate